首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise
Authors:Juri Park MD  PhD  Sung Woo Park MD  PhD  Kun Ho Yoon MD  PhD  Sung Rae Kim MD  PhD  Kyu Jeung Ahn MD  PhD  Jae Hyuk Lee MD  PhD  Ji Oh Mok MD  PhD  Choon Hee Chung MD  PhD  Kyung Ah Han MD  PhD  Gwan Pyo Koh MD  PhD  Jun Goo Kang MD  PhD  Chang Beom Lee MD  PhD  Seong Hwan Kim MD  PhD  Na Young Kwon MSc  Doo Man Kim MD  PhD
Affiliation:1. Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea;2. Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea;3. Department of Endocrinology and Metabolism, Division of Internal Medicine, Seoul St Mary's Hospital, Catholic University of Korea, Seoul, Korea;4. Department of Endocrinology and Metabolism, Division of Internal Medicine, Bucheon St. Mary's Hospital, Catholic University of Korea, Bucheon, Korea;5. Department of Endocrinology and Metabolism, Division of Internal Medicine, Kangdong Kyung Hee Hospital, Kyung Hee University School of Medicine, Seoul, Korea;6. Department of Endocrinology and Metabolism, Division of Internal Medicine, Myongji Hospital, Kwandong University College of Medicine, Koyang, Korea;7. Department of Endocrinology and Metabolism, Division of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea;8. Department of Endocrinology and Metabolism, Division of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea;9. Department of Endocrinology and Metabolism, Division of Internal Medicine, Eulji University School of Medicine, Daejeon, Korea;10. Department of Endocrinology and Metabolism, Division of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea;11. Department of Endocrinology and Metabolism, Division of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea;12. Department of Endocrinology and Metabolism, Division of Internal Medicine, Hanyang University Guri Hospital, Hanyang University Medical School, Guri, Korea;13. Department of Cardiology, Division of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea;14. Division of Biostatistics, Clinical Development Team, Dong‐A ST Co., LTD., Seoul, Korea
Abstract:
Keywords:antidiabetic drug  clinical trial  DPP‐4 inhibitor  phase III study  type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号